Transcranial brain parenchyma sonography in patients with juvenile myoclonic epilepsy.
Basal ganglia
Juvenile myoclonic epilepsy
Red nucleus
Substantia nigra
Transcranial brain parenchyma sonography
Journal
Acta neurologica Belgica
ISSN: 2240-2993
Titre abrégé: Acta Neurol Belg
Pays: Italy
ID NLM: 0247035
Informations de publication
Date de publication:
21 Apr 2024
21 Apr 2024
Historique:
received:
08
02
2024
accepted:
15
04
2024
medline:
22
4
2024
pubmed:
22
4
2024
entrez:
21
4
2024
Statut:
aheadofprint
Résumé
There are rising evidences that subcortical structures, including the basal ganglia, are affected in patients with epilepsy. These structures are thought to influence the modulation and phenotypic expression of epileptic seizures. Our study aimed to evaluate the presence of structural abnormalities in subcortical structures in patients with juvenile myoclonic epilepsy (JME). This cross-sectional study included 51 patients who were diagnosed with JME and who were monitored on an outpatient basis at the Clinic for Neurology and Psychiatry for Children and Youth in Belgrade from January 1985 to October 2017. All patients underwent transcranial parenchymal sonography (TCS) from October 2015 to October 2017. Relation of clinical parameters (seizure control andcognitive functioning,) with TCS results was assessed. Hyperechogenicity of the substantia nigra (SN) was detected in 37.2% of JME subjects and it was significantly more common in patients with JME than in the control group. The marked echogenicity of the red nucleus (RN) was detected in 17.6% of cases, while 11.8% of subjects had hyperechogenic RN. The presence of hyperechogenic RN (both right and left) was significantly more frequent in the group of patients with JME compared to the control group. The third ventricle diameter was larger in patients with JME than in controls. Structural changes of certain subcortical structures, primarily SN and RN, detected in JME patients indicate additional non-lesional abnormalities of the basal ganglia and midbrain structures in these patients.
Identifiants
pubmed: 38644442
doi: 10.1007/s13760-024-02561-6
pii: 10.1007/s13760-024-02561-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
ID : 451-03-66/2024-03/200110
Informations de copyright
© 2024. The Author(s) under exclusive licence to Belgian Neurological Society.
Références
Commission on Classification and Terminology of the International League Against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399. https://doi.org/10.1111/j.1528-1157.1989.tb05316.x
doi: 10.1111/j.1528-1157.1989.tb05316.x
Crespel A, Gelisse P, Reed RC, Ferlazzo E, Jerney J, Schmitz B, Genton P (2013) Management of juvenile myoclonic epilepsy. Epilepsy Behav 28(Suppl 1):S81-86. https://doi.org/10.1016/j.yebeh.2013.01.001
doi: 10.1016/j.yebeh.2013.01.001
pubmed: 23756489
Genton P, Thomas P, Kasteleijn-Nolst Trenité DGA, Medina MT, Salas-Puig J (2013) Clinical aspects of juvenile myoclonic epilepsy. Epilepsy Behav 28(Suppl 1):S8-14. https://doi.org/10.1016/j.yebeh.2012.10.034
doi: 10.1016/j.yebeh.2012.10.034
pubmed: 23756488
Baykan B, Peter Wolf P (2017) Juvenile myoclonic epilepsy as a spectrum disorder: a focused review. Seizure 49:36–41. https://doi.org/10.1016/j.seizure.2017.05.011
doi: 10.1016/j.seizure.2017.05.011
pubmed: 28544889
Saini J, Sinha S, Bagepally BS, Ramchandraiah CT, Thennarasu K, Prasad C, Taly AB, Satishchandra P (2013) Subcortical structural abnormalities in juvenile myoclonic epilepsy (JME): MR volumetry and vertex based analysis. Seizure 22(3):230–235. https://doi.org/10.1016/j.seizure.2013.01.001
doi: 10.1016/j.seizure.2013.01.001
pubmed: 23340274
Hattingen E, Lückerath C, Pellikan S, Vronski D, Roth C, Knake S, Kieslich M, Pilatus U (2014) Frontal and thalamic changes of GABA concentrationindicate dysfunction of thalamofrontal networks in juvenilemyoclonic epilepsy. Epilepsia 55(7):1030–1037. https://doi.org/10.1111/epi.12656
doi: 10.1111/epi.12656
pubmed: 24902613
Landvogt C, Buchholz HG, Bernedo V, Schreckenberger M, Werhahn KJ (2010) Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy. Epilepsia 51(9):1699–1706. https://doi.org/10.1111/j.1528-1167.2010.02569.x
doi: 10.1111/j.1528-1167.2010.02569.x
pubmed: 20384765
Depaulis A, Moshé SL (2002) Editorial the basal ganglia and epilepsies: translating experimental concepts to new therapies. Epileptic Disord 4(Suppl 3):S7-8
pubmed: 12495870
Slaght SJ, Paz T, Mahon S, Maurice N, Charpier S, Deniau JM (2002) Functional organisation of the circuits connecting the cerebral cortex and the basal ganglia: implications for the role of the basal ganglia in epilepsy. Epileptic Disord 4(Suppl 3):S9-22
pubmed: 12495871
Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7(11):1044–1055. https://doi.org/10.1016/S1474-4422(08)70239-4
doi: 10.1016/S1474-4422(08)70239-4
pubmed: 18940694
Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic parkinson’s disease visualized by transcranial color-coded real-time sonography. Neurology 45(1):182–184. https://doi.org/10.1212/wnl.45.1.182
doi: 10.1212/wnl.45.1.182
pubmed: 7824114
Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76(3):423–425. https://doi.org/10.1136/jnnp.2004.049221
doi: 10.1136/jnnp.2004.049221
pubmed: 15716540
pmcid: 1739539
Berg D (2011) Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for parkinson’s disease. J Neural Transm (Vienna) 118(3):453–461. https://doi.org/10.1007/s00702-010-0469-5
doi: 10.1007/s00702-010-0469-5
pubmed: 20830493
Mijajlović M, Petrović I, Stojković T, Svetel M, Stefanova E, Kostić VS (2008) [Transcranial parenchymal sonography in the diagnosis of parkinson’s disease]. Vojnosanit Pregl 65(8):601–605. https://doi.org/10.2298/vsp0808601m . (Serbian)
doi: 10.2298/vsp0808601m
pubmed: 18751340
Mijajlovic MD (2010) Transcranial sonography in depression. Int Rev Neurobiol 90:259–272. https://doi.org/10.1016/S0074-7742(10)90018-4
doi: 10.1016/S0074-7742(10)90018-4
pubmed: 20692507
Krogias C, Walter U (2016) Transcranial sonography findings in depression in association with psychiatric and neurologic diseases: a review. J Neuroimaging 26(3):257–263. https://doi.org/10.1111/jon.12328
doi: 10.1111/jon.12328
pubmed: 27119431
Şenel B, Özel-Kızıl ET, Sorgun MH, Tezcan-Aydemir S, Kırıcı S (2020) Transcranial sonography imaging of brainstem raphe, substantia nigra and cerebral ventricles in patients with geriatric depression. Int J Geriatr Psychiatry 35(7):702–711. https://doi.org/10.1002/gps.5287
doi: 10.1002/gps.5287
pubmed: 32100326
Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D (2005) Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 64(10):1726–1732. https://doi.org/10.1212/01.WNL.0000161847.46465.B9
doi: 10.1212/01.WNL.0000161847.46465.B9
pubmed: 15911799
Svetel M, Mijajlović M, Tomić A, Kresojević N, Pekmezović T, Kostić VS (2012) Transcranial sonography in Wilson’s disease. Parkinsonism Relat Disord 18(3):234–238. https://doi.org/10.1016/j.parkreldis.2011.10.007
doi: 10.1016/j.parkreldis.2011.10.007
pubmed: 22024248
Mijajlović M, Dragasević N, Stefanova E, Petrović I, Svetel M, Kostić VS (2008) Transcranial sonography in spinocerebellar ataxia type 2. J Neurol 255(8):1164–1167. https://doi.org/10.1007/s00415-008-0862-2
doi: 10.1007/s00415-008-0862-2
pubmed: 18458857
Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological Assessment, 5th edn. Oxford University Press
Tombaugh TN (2004) Trail making test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 19(2):203–214. https://doi.org/10.1016/S0887-6177(03)00039-8
doi: 10.1016/S0887-6177(03)00039-8
pubmed: 15010086
Golden CJ (2004) The Adult Luria-Nebraska Neuropsychological Battery. In: Goldstein G, Beers SR, Hersen M (eds) Comprehensive handbook of psychological assessment, intellectual and neuropsychological assessment, vol 1. John Wiley & Sons Inc, Hoboken, NJ, US, pp 133–146
Walter U, Školoudík D (2004) Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies. Ultraschall Med 35(4):322–331. https://doi.org/10.1055/s-0033-1356415
doi: 10.1055/s-0033-1356415
Godau J, Wevers AK, Gaenslen A, Di Santo A, Liepelt I, Gasser T, Berg D (2008) Sonographic abnormalities of brainstem structures in restless legs syndrome. Sleep Med 9(7):782–789. https://doi.org/10.1016/j.sleep.2007.09.001
doi: 10.1016/j.sleep.2007.09.001
pubmed: 18024170
Raatikainen M, Kälviäinen R, Jutila L, Äikiä M (2020) Cognitive functioning in new-onset juvenile myoclonic epilepsy. Epilepsy Behav 106:107015. https://doi.org/10.1016/j.yebeh.2020.107015
doi: 10.1016/j.yebeh.2020.107015
pubmed: 32179503
Camfield CS, Striano P, Camfield PR (2013) Epidemiology of juvenile myoclonic epilepsy. Epilepsy Behav 28(Suppl 1):S15–S17. https://doi.org/10.1016/j.yebeh.2012.06.024
doi: 10.1016/j.yebeh.2012.06.024
pubmed: 23756473
Jovic N (2012) Frontal lobe dysfunctions in patients with juvenile myoclonic epilepsy. J Ped Epilepsy 2:77–85
Vuong J, Devergnas A (2018) The role of the basal ganglia in the control of seizure. J Neural Transm (Vienna) 125(3):531–545. https://doi.org/10.1007/s00702-017-1768-x
doi: 10.1007/s00702-017-1768-x
pubmed: 28766041
Kim JH, Kim JB, Suh S, Kim DW (2017) Subcortical grey matter changes in juvenile myoclonic epilepsy. Neuroimage Clin 17:397–404. https://doi.org/10.1016/j.nicl.2017.11.001
doi: 10.1016/j.nicl.2017.11.001
pubmed: 29159052
pmcid: 5683808
Trinka E, Kienpointner G, Unterberger I, Luef G, Bauer G, Doering LB, Doering S (2006) Psychiatric comorbidity in juvenile myoclonic epilepsy. Epilepsia 47(12):2086–2091. https://doi.org/10.1111/j.1528-1167.2006.00828.x
doi: 10.1111/j.1528-1167.2006.00828.x
pubmed: 17201708
Filho GM, Rosa VP, Lin K, Caboclo LO, Sakamoto AC, Yacubian EM (2008) Psychiatric comorbidity in epilepsy: a study comparing patients with mesial temporal sclerosis and juvenile myoclonic epilepsy. Epilepsy Behav 13(1):196–201. https://doi.org/10.1016/j.yebeh.2008.01.008
doi: 10.1016/j.yebeh.2008.01.008
pubmed: 18313989
Iadarola MJ, Gale K (1982) Substantia nigra: site of anticonvulsant activity mediated by g-aminobutyric acid. Science 218(4578):1237–1240. https://doi.org/10.1126/science.7146907
doi: 10.1126/science.7146907
pubmed: 7146907
Velísková J, Moshé SL (2006) Update on the role of substantia nigra pars reticulata in the regulation of seizures. Epilepsy Curr 6(3):83–87. https://doi.org/10.1111/j.1535-7511.2006.00106.x
doi: 10.1111/j.1535-7511.2006.00106.x
pubmed: 16761069
pmcid: 1464157
Albala BJ, Moshé SL, Okada R (1984) Kainic-acid-induced seizures: a developmental study. Dev Brain Res 315(1):139–148. https://doi.org/10.1016/0165-3806(84)90085-3
doi: 10.1016/0165-3806(84)90085-3
Ben-Ari Y, Tremblay E, Riche D, Ghilini G, Naquet R (1981) Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6(7):1361–1391. https://doi.org/10.1016/0306-4522(81)90193-7
doi: 10.1016/0306-4522(81)90193-7
pubmed: 7266871
Chen B, Xu C, Wang Y, Lin W, Wang Y, Chen L, Cheng H, Xu L, Hu T, Zhao J, Dong P, Guo Y, Zhang S, Wang S, Zhou Y, Hu W, Duan S, Chen Z (2020) A disinhibitory nigra-parafascicular pathway amplifies seizure in temporal lobe epilepsy. Nat Commun 11(1):923. https://doi.org/10.1038/s41467-020-14648-8
doi: 10.1038/s41467-020-14648-8
pubmed: 32066723
pmcid: 7026152
Velísková J, Miller AM, Nunes ML, Brown LL (2005) Regional neural activity within the substantia nigra during peri-ictal flurothyl generalized seizure stages. Neurobiol Dis 20(3):752–759. https://doi.org/10.1016/j.nbd.2005.05.007
doi: 10.1016/j.nbd.2005.05.007
pubmed: 15950481
pmcid: 1578684
Sperber EF, Wurpel JND, Zhao DY, Moshé SL (1989) Evidence for the involvement of nigral GABAa receptors in seizures of adult rats. Brain Res 480(1–2):378–382. https://doi.org/10.1016/0006-8993(89)90211-4
doi: 10.1016/0006-8993(89)90211-4
pubmed: 2540881
Ciumas C, Wahlin TB, Jucaite A, Lindstrom P, Halldin C, Savic I (2008) Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy. Neurology 71(11):788–794. https://doi.org/10.1212/01.wnl.0000316120.70504.d5
doi: 10.1212/01.wnl.0000316120.70504.d5
pubmed: 18463366
Habas C, Guillevin R, Abanou A (2010) In vivo structural and functional imaging of the human rubral and inferior olivary nuclei: a mini-review. Cerebellum 9(2):167–173. https://doi.org/10.1007/s12311-009-0145-1
doi: 10.1007/s12311-009-0145-1
pubmed: 19898914
Lefebvre V, Josien E, Pasquier F, Steinling M, Petit H (1993) Infarctus du noyau rouge et diaschisis cérébelleux croisé. Rev Neurol (Paris) 149(4):294–296 (French)
pubmed: 8235230
Kalnin AJ, Fastenau PS, deGrauw TJ, Musick BS, Perkins SM, Johnson CS, Mathews VP, Egelhoff JC, Dunn DW, Austin JK (2008) Magnetic resonance imaging findings in children with a first recognized seizure. Pediatr Neurol 39(6):404–414. https://doi.org/10.1016/j.pediatrneurol.2008.08.008
doi: 10.1016/j.pediatrneurol.2008.08.008
pubmed: 19027586
pmcid: 2677696
Jackson DC, Irwin W, Dabbs K, Lin JJ, Jones JE, Hsu DA, Stafstrom CE, Seidenberg M, Hermann BP (2011) Ventricular enlargement in new-onset pediatric epilepsies. Epilepsia 52(12):2225–2232. https://doi.org/10.1111/j.1528-1167.2011.03323.x
doi: 10.1111/j.1528-1167.2011.03323.x
pubmed: 22091816
pmcid: 3347640